Method of inhibiting lipogenesis with ubiquitin-specific peptidase 24 inhibitor composition
AssigneeNational Cheng Kung University
InventorChien-Chung HUNG
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of inhibiting lipogenesis with a ubiquitin-specific peptidase 24 (USP24) inhibitor composition. The USP24 inhibitor composition, which includes a carbonyl substituted phenyl compound, can specifically inhibit lipogenesis and hepatic lipid accumulation in a high-fat individual, thereby being applied to a method of inhibiting lipogenesis and hepatic lipid accumulation in a high-fat subject.
Claims10
A method of inhibiting lipogenesis with a ubiquitin-specific peptidase (USP) 24 inhibitor composition, wherein the USP 24 inhibitor composition comprises carbonyl-substituted phenyl compound and/or its salt as an active ingredient, as shown in formula (I):
- in formula (I), X1 represents a single bond, n1 represents an integer of 1 or 2, Y represents a monovalent group, X2 represents a hydrogen atom or a hydroxyl group, and the salts of said carbonyl-substituted phenyl compound are selected from a group consisting of oxalates, phosphates, sulfates, and hydrochlorides, and
- wherein when X1 represents the single bond, n1 represents the integer 1, in formula (I-1), R1 represents an alkyl piperazine group as shown in formula (I-2), where # represents a connecting point with one nitrogen atom of the thiazine group (I-1), and n2 represents an integer from 1 to 4:
- wherein when X2 represents a hydrogen atom, Y represents a monovalent group having a thiazine group as shown in formula (I-1), and * in formula (I-1) represents a connecting point with X1
A method of inhibiting hepatic lipid accumulation with a USP 24 inhibitor composition, wherein the USP 24 inhibitor composition comprises carbonyl-substituted phenyl compound and/or its salt as an active ingredient, as shown in formula (I):
- in formula (I), X1 represents a single bond, n1 represents an integer of 1 or 2, Y represents a monovalent group, X2 represents a hydrogen atom or a hydroxyl group, and the salts of said carbonyl-substituted phenyl compound are selected from a group consisting of oxalates, phosphates, sulfates, and hydrochlorides, and
- wherein when X1 represents the single bond, n1 represents the integer 1, in formula (I-1), R1 represents an alkyl piperazine group as shown in formula (I-2), where # represents a connecting point with one nitrogen atom of the thiazine group (I-1), and n2 represents an integer from 1 to 4
- wherein when X2 represents a hydrogen atom, Y represents a monovalent group having a thiazine group as shown in formula (I-1), and * in formula (I-1) represents a connecting point with X1,
- wherein the carbonyl-substituted phenyl compound is administered to an individual at an effective dose of 5 mg/kg body weight to 20 mg/kg body weight.
A method of inhibiting the expression of PPAR-γ and/or PLIN1 genes with a USP 24 inhibitor composition, wherein the USP 24 inhibitor composition comprises carbonyl-substituted phenyl compound and/or its salt as an active ingredient, as shown in formula (I-3-1):
- thereby reducing the expression levels of PPAR-γ and/or PLIN1 genes in test cells.
Dependencies are inferred from the claim text.